arrow
H

Harry J.G.M. Crijns

Maastricht University
H指数:126
被引数:10.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Early rhythm control in patients with atrial fibrillation and cancer: A subgroup analysis of the EAST-AFNET 4 trial

房颤合并癌症患者早期节律控制:EAST-AFNET 4试验的亚组分析

2026-09-180
OAAI
Pacemaker-implantation and atrioventricular-node ablation vs pulmonary vein isolation for elderly patients with persistent atrial fibrillation: the ABLATE versus PACE trial

起搏器植入和房室结消融与肺静脉隔离治疗老年持续性心房颤动患者的比较:ABLATE与PACE试验

2026-08-310
OAAI
Low-dose digoxin in patients with heart failure with reduced or mildly reduced ejection fraction: a randomized controlled trial

低剂量地高辛在射血分数降低或轻度降低的心力衰竭患者中的应用:一项随机对照试验

2026-05-100
OAAI
Real-world anticoagulant use and clinical outcomes in postoperative atrial fibrillation after coronary artery bypass grafting: a nationwide practice-based cohort from The Netherlands Heart Registration

冠状动脉旁路移植术后房颤患者的实际抗凝药物使用及临床结局:一项来自荷兰心脏登记系统的全国实践队列研究

2025-11-011
PRE
Prevalence and severity of atrial cardiomyopathy in patients with recently diagnosed atrial fibrillation and stroke risk factors and its association with early rhythm control: a secondary analysis of EAST-AFNET 4

新近诊断房颤且伴有卒中风险因素患者中心房心肌病的患病率与严重程度及其与早期节律控制的关联:EAST-AFNET 4研究的二次分析

2025-10-010
OAAI
Estimated atrial fibrillation burden on early rhythm-control and cardiovascular events in the EAST-AFNET 4 trial

EAST-AFNET 4试验中早期节律控制对估计心房颤动负荷及心血管事件的影响

2025-09-010
OAAI
Anticoagulation and thromboembolic risk in critically ill patients with trigger-induced atrial fibrillation-A systematic review and meta-analysis (Jul, 10.1007/s12471-025-01978-9, 2025)

抗凝治疗及血栓栓塞风险在危重症触发因素诱导的心房颤动患者中的研究——系统评价与Meta分析(2025年7月,10.1007/s12471-025-01978-9)

2025-09-010
OAAI
Sex and Treatment Outcomes of Atrial Fibrillation Ablation in End-Stage Heart Failure

心房颤动消融在终末期心力衰竭中的性别与治疗效果

2025-08-130
OAAI
Recent-onset atrial fibrillation: challenges and opportunities

新发心房颤动:挑战与机遇

2025-08-0112
PRE
Short-term benefit of early rhythm control for atrial fibrillation: the EAST-AFNET 4 trial

心房颤动早期节律控制的短期获益:EAST-AFNET 4试验

2025-07-013
OAAI
Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology

抗心律失常药物实用汇编:欧洲心脏节律协会(ESC)的临床共识声明

2025-03-300
OA
Multimorbidity Is Associated With Symptom Severity and Disease Progression in Patients with Paroxysmal Atrial Fibrillation-Data From the RACE V Study

多发病与阵发性心房颤动患者的症状严重程度和疾病进展相关-来自RACE V研究的数据

2025-02-260
OAAI
Lateral Atrial Expression Patterns Provide Insights into Local Transcription Disequilibrium Contributing to Disease Susceptibility
2025-02-010
PRE
Spotlight on the 2024 ESC/EACTS management of atrial fibrillation guidelines: 10 novel key aspects

聚焦2024年ESC/EACTS房颤管理指南:10大全新关键要点

2024-12-240
OAAI
Dynamic biomarker profiles in patients with paroxysmal atrial fibrillation: Assessing the differences between sinus rhythm and acute atrial fibrillation episode

阵发性房颤患者的动态生物标志物谱: 评估窦性心律和急性房颤发作之间的差异

2024-12-013
OAAI